Institution
Duran i Reynals Hospital
- 39running trials
- 30closed trials
- 2,957publications (OpenAlex)
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
M9466 Alone or in Combination in Advanced Solid Tumors (DDriver 501)
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
A Phase 1/2 Study of IDP-121 in Patients With Relapsed/Refractory Hematologic Malignancies
Recruiting
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)
Active, not recruiting
Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.
Recruiting
Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access
Active, not recruiting
Active, not recruiting
Active, not recruiting
Trial of Preoperative Therapy for Gastric and Esophagogastric Junction Adenocarcinoma
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic lymphocytic leukaemia3 recruiting
- Colorectal cancer3 recruiting
- Gastric and oesophageal cancer3 recruiting
- Lung cancer3 recruiting
- Childhood cancers2 recruiting
- Liver and biliary tract cancer2 recruiting
- Melanoma2 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Head and neck cancer1 recruiting
- Kidney cancer1 recruiting
- Mesothelioma1 recruiting
- Metastatic breast cancer1 recruiting
- Multiple myeloma1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Sarcoma1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Terminated
A Study of NUC-3373 in Combination With Other Agents in Patients With Colorectal Cancer
Recruiting
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
Terminated
Completed
Completed
Phase I/II stUdy of ALoCelyvir in patientS with mEtastaticUveal Melanoma (PULSE-UM)
Terminated
Terminated
A Study of HMPL-306 in Advanced Hematological Malignancies With mIDH
Completed
Completed
Completed
Study of Lorlatinib In People With ALK-positive Non-small Cell Lung Cancer
Completed
Completed
Completed
Completed
Terminated
Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors
Terminated
Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (MCL)
Completed
Completed
Completed
Completed
Completed
Registry name variants (48)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
ICO l'Hospitalet - Hospital Duran i Reynals
Barcelona, 08906
22 trials
Ico L'Hospitalet - Hospital Duran I Reynals
L'Hospitalet de Llobregat, 08908
11 trials
Hospital Duran i Reynals
L'Hospitalet de Llobregat, 08908
5 trials
Hospital Duran i Reynals
Barcelona, 08908
3 trials
Institut Català d'Oncologia - Hospital Duran i Reynals (ICO L'Hospitalet)
Barcelona, 08908
3 trials
Catalan Institute of Oncology, Hospital Duran i Reynals
Barcelona, Catalonia 08908
2 trials
ICO L'Hospitalet - Hospital Duran i Reynals (Institut Catala D'Oncologia)
L'Hospitalet de Llobregat, 08908
2 trials
NCT02834884SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access
Contact: EORTC HQ
NCT01924819Trial of Preoperative Therapy for Gastric and Esophagogastric Junction Adenocarcinoma
Institut Catala d'Oncologia - ICO L'Hospitalet - Hospital Duran i Reynals
L'Hospitalet de Llobregat, Barcelona 08908
2 trials
Catalan Institute of Oncology, Hospital Duran i Reynals, Department of Clinical Hematology
L'Hospitalet de Llobregat, 08908
1 trial
NCT06782373A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)
Contact: Study Physician
Hospital Duran i Reynals (Adults and Pediatrics)
Badalona, BARCELONA 8908
1 trial
Hospital Duran i Reynals - ICO L Hospitalet
L'Hospitalet de Llobregat, 08908
1 trial
Hospital Durán i Reynals - ICO L´Hospitalet
Barcelona
1 trial
NCT05908409A Phase 1/2 Study of IDP-121 in Patients With Relapsed/Refractory Hematologic Malignancies
Contact: Anna María Sureda Balari (principal investigator)
HOSPITAL DURAN I REYNALS - ICO Oncologia
Barcelona, 08908
1 trial
Hospital Duran i Reynals
L'Hospitalet de Llobregat, Barcelona 08907
1 trial
Hospital Duran i Reynals (Site 1053)
L'Hospitalet de Llobregat, 08907
1 trial
Hospital Duran i Reynals (Site 2701)
L'Hospitalet de Llobregat, Barcelona 08908
1 trial
ICO l'Hospitalet - Hospital Duran i Reynals - Servicio de Oncologia
Barcelona
1 trial
ICO l'Hospitalet - Hospital Duran i Reynals - Servicio de Oncologia
L'Hospitalet de Llobregat, 08908
1 trial
Institit Catala D'Oncologia - Hospital Duran i Reynals
L'Hospitalet de Llobregat, 8908
1 trial
Institut Catalá de Oncologia - Hospital Duran i Reynals.
Barcelona
1 trial
NCT04855435Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours
Contact: José M Piulats Rodríguez, MD, PhD
Institut Català d'Oncologia de l'Hospitalet de Llobregat - Hospital Duran i Reynals
Barcelona, 08908
1 trial
Institut Catala d'Oncologia - Hospital Duran i Reynals (ICO L'Hospitalet)
L'Hospitalet de Llobregat, Catalunya [cataluña] 08908
1 trial
Contact: Caroline Chevalier, MSc, MPH
Institut Catala d'Oncologia (ICO) - Hospital Duran i Reynals,
Barcelona, 08908
1 trial
Contact: Clinical Study Coordinator
Institut Catala d'Oncologis (ICO) - Hospital Duran i Reynals
Barcelona, 8013
1 trial
Instituto Catalan de Oncologia ICO - Hospital Duran i Reynals
L'Hospitalet de Llobregat, Barcelona 8908
1 trial
Instituto Catalan de Oncologia ICO - Hospital Duran i Reynals (Site 2000)
L'Hospitalet de Llobregat, Barcelona 08908
1 trial
Contact: Study Coordinator
Instituto Catalan de Oncologia ICO - Hospital Duran i Reynals (Site 3403)
L'Hospitalet de Llobregat, Barcelona 08908
1 trial
Catalan Institute of Oncology, Hospital Duran i Reynals
L'Hospitalet de Llobregat, 08908
Hospital Duran i Reynals (ICO)
L'Hospitalet de Llobregat, Barcelona 08908
Hospital Duran i Reynals
L'Hospitalet de Llobregat, Barcelona 08907
Hospital Duran i Reynals
L'Hospitalet de Llobregat, Barcelona 08907
Hospital Duran i Reynals - Institut Catala dOncologia ICO
L'Hospitalet de Llobregat, 08908
Hospital Duran i Reynals - Institut Catala d'Oncologia L'Hospitalet (ICO L'Hospitalet)
L'Hospitalet de Llobregat, Barcelona 08908
Hospital Duran i Reynals (Site 1710)
L'Hospitalet de Llobregat, Barcelona 08908
Hospital Duran i Reynals (Site 1903)
L'Hospitalet de Llobregat, Barcelona 08908
ICO - Hospital Duran i Reynals (Site 0301)
L'Hospitalet de Llobregat, Barcelona 08908
ICO L'Hospitalet - Hospital Duran i Reynals (Institut Catala D'Oncologia)
Barcelona, 08908
Institut Catala di Oncologia - Hospital Duran i Reynals
Barcelona
Institut Catala D Oncolocia Hospitalet - Hospital Duran i Reynals
Barcelona
Institut Català d'Oncologia - Hospital Duran i Reynals
Badalona, 08916
Institut Catala d'Oncologia (ICO) - Hospital Duran i Reynals
L'Hospitalet de Llobregat, Barcelona 08908
Institut Catala D'Oncologia (ICO L'Hospitalet) Hospital Duran i Reynals
Barcelona, 08908
Institut Catala d'Oncologia - ICO L'Hospitalet - Hospital Duran i Reynals (Institut Catala D'Oncologia)
L'Hospitalet de Llobregat, 08908
Instituto Catalan de Oncologia - Hospital Duran i Reynals
Barcelona, 8908
Instituto Catalan de Oncologia - Hospital Duran i Reynals (Site 2403)
L'Hospitalet de Llobregat, Catalonia 08908
Instituto Catalan de Oncologia - Hospital Duran i Reynals (Site 3403)
L'Hospitalet de Llobregat, Catalonia 08908
Instituto Catalan de Oncologia ICO - Hospital Duran i Reynals (Site 0700)
L'Hospitalet de Llobregat, Barcelona 08908
Instituto Catalan de Oncologia ICO - Hospital Duran i Reynals (Site 1603)
L'Hospitalet de Llobregat, Barcelona 08909
Institution data: ROR 03qwghy04 (CC0-1.0)Updated 7 Nov 2026